参考文献/References:
[1] 甄丽芳，凌敏．肺癌早期诊断现状与未来展望 [J]．临床肺科杂志 ,2017,22(3):549-553. ZHEN Lifang.LING Min.Current status and future prospects of early diagnosis of lung cancer[J]. Journal of Clinical Pulmonary Medicine ,2017,22(3):549-553.
[2] GAO Wanlei, WANG Wentao, YAO Shihua, et al. Highly sensitive detection of multiple tumor markers for lung cancer using gold nanoparticle probes and microarrays[J]. Analytica Chimica Acta, 2017, 958: 77-84.
[3] 刘延梅，马少君，马庆，等．非小细胞肺癌患者组织 EGFR基因突变状况及预后分析 [J]．现代检验医学杂志，2019, 34(1):22-25. LIU Yanmei, MA Shaojun, MA Qing, et al. Analysis of the status and outcome of epidermal growth factor receptor mutations in non-small cell lung cancer patients[J]. Journal of Modern Laboratory Medicine, 2019, 34(1):22-25.
[4] 张萍 , 王红义 , 杨迎桂 , 等 .血清 CEA, ProGRP, NSE和 CYFRA21-1联合检测在肺癌诊断中的应用研究 [J].现代检验医学杂志 , 2016, 31（2）: 56-59. ZHANG Ping,WANG Hongyi,YANG Yinggui,et al. Clinical application of combined detection of CEA, ProGRP, NSE and CYFRA21-1 in diagnosis of lung cancer [J] .Journal of Modern Laboratory Medicine,,2016,31(2):56-59.
[5] AISNER D L. The revised college of american pathologists/international association for the study of lung cancer/association for molecular pathology guideline: A step forward for molecular cytopathology [J]. Archives of Pathology & Laboratory Medicine, 2018, 142(6): 684-685.
[6] 中华医学会 , 中华医学会肿瘤学分会 ,中华医学会杂志社 .中华医学会肺癌临床诊疗指南 (2018版 )[J].中华肿瘤杂志 ,2018,40(12):935-964. Chinese Medical Association,Oncology Society of Chinese Medical Association,Chinese Medical Association Publishing House. Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer ( Edition 2018) [J]Chinese Journal of Oncology,2018,40(12):935-964.
[7] GAO Li, XIE Sheng, LIU Hui, et al. Lung cancer in patients with combined pulmonary fibrosis and emphysema revisited with the 2015 World Health Organization classification of lung tumors[J]. The Clinical Respiratory Journal, 2018, 12(2): 652-658.
[8] KATAOKA Y, HIRANO K, NARABAYASHI T, et al. Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort study[J]. Cancer Chemotherapy and Pharmacology, 2018, 81(2): 333-337.
[9] 张仁锋，张岩，温丰标，等． 6 058例肺癌患者病理类型和临床流行病学特征的分析 [J]．中国肺癌杂志 , 2016, 19（3）:129-135. ZHANG Renfeng,ZHANG Yan,WEN Fengbiao,et al. Analysis of pathological types and clinical epidemiology of 6 058 patients with lung cancer [J]. Chinese Journal of Lung Cancer,2016,19(3):129-135.
[10] 陆舜，虞永峰，纪文翔． 2015年肺癌诊疗指南 :共识和争议 [J]．解放军医学杂志， 2016, 41（1）: 1-6. LU Shun,YU Yongfeng,JI Wenxiang. Guidelines for lung cancer in 2015: Consensus and controversy [J]. Medical Journal of Chinese People’s Liberation Army,2016,41(1):1-6.
[11] 尹志辉，周志伟，刘继勇，等．乳腺癌患者组织多项组化标记物与血清 CA153,CA125,CEA,25-OH-D3水平关联性分析模型建立及在预后判断的临床价值 [J].现代检验医学杂志 ,2019,34(3):47-54. YIN Zhihui,ZHOU Zhiwei,LIU Jiyong,et al. Establishment of a correlation analysis model between multi-group markers and serum CA153 ,CA125 ,CEA,25-OH-D3 in breast cancer patients and clinical value in prognosis[J] . Journal of Modern Laboratory Medicine ,2019,34(3):47-54.
[12] ABU HASSAAN S O. Monitoring ovarian cancer patients during chemotherapy and follow-up with the serum tumor marker CA125[J]. Danish Medical Journal, 2018, 65(4): 5463-5468.
[13] 熊娟．多种血清肿瘤标志物 (CY211,NSE,CEA,-CA125,CA199,SCC)对不同病理类型和临床分期肺癌的诊断价值 [J].中国社区医师 , 2017, 33(3):99-100. XIONG Juan. Diagnostic value of multiple serum tumor markers(CY211,NSE,CEA,CA125,CA199,S CC) in different pathological types and clinical stages of lung cancer[J]. Chinese Community Doctors, 2017, 33(3):99-100.
[14] 刘涛 , 杨燕 , 刘博 , 等 .联合检测胸腹腔积液 sCD44V6,CEA,CYFRA21-1,CA199,NSE,CA125对良恶性疾病鉴别诊断价值研究 [J]．现代检验医学杂志， 2020, 35（2）: 53-55, 64. LIU Tao,YANG Yan,LIU Bo,et al. Value of combined detection of sCD44V6, CEA, CYFRA21-1, CA199, NSE and CA125 in the differential diagnosis of benign and malignant pleural and peritoneal effusion [J].Journal of Modern Laboratory Medicine,2020,35(2):53-55,64.
[15] 王媛媛，刘婉，王萍，等．血清 CYFRA21-1,SCC-Ag,LDH联合检测对肺鳞癌与肺部感染鉴别诊断的价值初探 [J]．现代肿瘤医学， 2018，26（13）： 2033-2036． WANG Yuanyuan,LIU Wan,WANG Ping.et al. Com-bined detection value of serum CYFRA21-1,SCC-Ag and LDH levels in the differ-ential diagnosis of lung squamous cell carcinoma and pneumonia[J].Journal of Modern Oncology,2018,26(13):2033-2036.
[16] GADGEEL S, GOSS G, SORIA J C, et al. Evaluation of the VeriStrat. serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study[J]. Lung Cancer (Amsterdam, Netherlands), 2017, 109(11): 101-108.
[17] 赵车冬 , 闫玉珠 , 吴文婧 , 等 .血清 CEA,CYFRA21-1和 NSE水平在肺癌诊断与分型中的应用价值 [J].现代检验医学杂志 ,2016,31(6):59-61,65. ZHAO Chedong,YAN Yuzhu,WU Wenjing, et al. Appli-cation value of serum CEA,CYFRA2 1-1 and NSE lev-els in the diagnosis and typing of lung cancer[J]. Journal of Modern Laboratory Medicine,2016,31(6):59-61,65.
[18] 李东航 , 姚颐 , 耿庆 .中国临床肿瘤学会肺癌诊疗指南 (2018版 )更新解读 [J].临床外科杂志 , 2019, 27（1）: 36-39. LI Donghang,YAO Yi, GENG Qing.Updated interpretation of Chinese society of clinical oncology guidelines for diagnosis and treatment of lung cancer (2018 Edition)[J].Journal of Clinical Surgery,2019,27(1):36-39.
[19] 郭九玲 ,扈成伟 ,李冬霞 ,等 .动态监测血清 CEA,CA19-9,CA125,CA153和 CYFRA21-1对肺癌患者围手术期疗效评估的临床研究 [J]．癌症进展 , 2019, 17（14）:1701-1703, 1725.
相似文献/References:
[1]张 萍a,王红义b,杨迎桂a,等.血清CEA,ProGRP,NSE和CYFRA21-1联合检测在肺癌诊断中的应用研究[J].现代检验医学杂志,2016,31(02):56.[doi:10.3969/j.issn.1671-7414.2016.02.017]
ZHANG Pinga,WANG Hong-yib,YANG Ying-guia,et al.Clinical Application of Combined Detection
of CEA,ProGRP,NSE and CYFRA21-1 in Diagnosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(01):56.[doi:10.3969/j.issn.1671-7414.2016.02.017]
[2]卢美红,鞠少卿,丛 辉,等.南通地区健康人群血清NSE电化学发光法检测参考区间的调查[J].现代检验医学杂志,2018,33(04):59.[doi:10.3969/j.issn.1671-7414.2018.04.015]
LU Mei-hong,JU Shao-qing,CONG Hui,et al.Investigate of Serum NSE Reference Range of Healthy People
in Nantong with Electrochemiluminescence[J].Journal of Modern Laboratory Medicine,2018,33(01):59.[doi:10.3969/j.issn.1671-7414.2018.04.015]
[3]彭 琦a,程少鹏b,陈辅萍a.非小细胞肺癌组织中NSE 的基因表达及与患者临床特征的相关性研究[J].现代检验医学杂志,2020,35(03):36.[doi:10.3969/j.issn.1671-7414.2020.03.008]
PENG Qia,CHENG Shao-pengb,CHEN Fu-pinga.Correlation between NSE Gene Expression and Serum NSE Level in Tumor Tissues
and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2020,35(01):36.[doi:10.3969/j.issn.1671-7414.2020.03.008]
[4]徐翠香,王建华,武 敏,等.胃癌患者血清CA724，NSE和 PGR水平联合检测对肿瘤临床病理分期及淋巴结转移的诊断价值[J].现代检验医学杂志,2021,36(01):6.[doi:10.3969/j.issn.1671-7414.2021.01.002]
XU Cui-xiang,WANG Jian-hua,WU Min,et al.Diagnostic Value of Combined Detection of Serum CA724, NSE and PGR Levels in Patients with Gastric Cancer for Tumor Clinical Pathological Stage and Lymph Node Metastasis[J].Journal of Modern Laboratory Medicine,2021,36(01):6.[doi:10.3969/j.issn.1671-7414.2021.01.002]
[5]朱 娇a,孙国才b,刘素荣a,等.食管癌患者血清神经元特异性烯醇化酶与长链非编码RNA ITGA9-AS1水平联合检测的实验诊断价值研究[J].现代检验医学杂志,2021,36(05):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
ZHU Jiaoa,SUN Guo-caib,LIU Su-ronga,et al.Experimental Diagnostic Value of Combined Detection of SerumNeuron-Specific Enolase and Long Non-Coding RNA ITGA9-AS1 inPatients with Esophageal Cancer[J].Journal of Modern Laboratory Medicine,2021,36(01):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
[6]董旭才,李 斌,曹聪聪,等.临床实验室单标本气动传输系统改进对血清NSE 和Cyfra21-1 检测结果的影响及效果评价[J].现代检验医学杂志,2023,38(04):169.[doi:10.3969/j.issn.1671-7414.2023.04.031]
DONG Xucai,LI Bin,CAO Congcong,et al.Effect and Evaluation of Single Specimen Pneumatic Transmission System Improvement on Serum NSE and Cyfra21-1 Detection in Clinical Laboratory[J].Journal of Modern Laboratory Medicine,2023,38(01):169.[doi:10.3969/j.issn.1671-7414.2023.04.031]